LSL Pharma Group

LSL Pharma Group FCF per Share

The Free Cash Flow per Share of LSL Pharma Group (LSL.V) as of Nov 1, 2026 is -0.06 CAD. In the previous year, Free Cash Flow per Share was -0.05 CAD — a change of 15.31% (lower).

FCF per Share

-0.06CAD

YoY

15.31%

Last updated:

Free Cash Flow per Share of LSL Pharma Group is 2025 -0.06 CAD. Free Cash Flow per Share of LSL Pharma Group was 2024 -0.05 CAD. It decreases by 15.31% lower compared to the previous year.

The LSL Pharma Group FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2020
-0.00 CAD
Jan 1, 2021
-0.02 CAD
Jan 1, 2022
-0.05 CAD
Jan 1, 2023
-0.10 CAD
Jan 1, 2024
-0.05 CAD
Jan 1, 2025
-0.06 CAD
The LSL Pharma Group FCF per Share history
YEARFCF per ShareYoY
-0.06CAD+15.31%
-0.05CAD-48.36%
-0.10CAD+93.86%
-0.05CAD+108.08%
-0.02CAD+883.38%
-0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

LSL Pharma Group Stock analysis

What does LSL Pharma Group do? LSL Pharma Group, Inc. generates revenue through the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The company operates as a pharmaceutical entity specializing in these specific therapeutic and wellness categories to meet market demand. The firm utilizes its subsidiaries, including Steri-Med Pharma Inc., LSL Laboratory Inc., and Groupe Immobilier LSL inc., to support its core operations. These entities facilitate the company's ability to produce and distribute its specialized pharmaceutical and supplement offerings effectively within its operational framework. LSL Pharma Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LSL Pharma Group stock

Free Cash Flow per Share of LSL Pharma Group is -0.06 CAD in 2025.

Free Cash Flow per Share of LSL Pharma Group changed from -0.05 CAD to -0.06 CAD, representing a 15.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share LSL Pharma Group since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — LSL Pharma Group

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — LSL Pharma Group